A phase II trial to investigate APX-001 in invasive candidiasis

Trial Profile

A phase II trial to investigate APX-001 in invasive candidiasis

Planning
Phase of Trial: Phase II

Latest Information Update: 04 Aug 2017

At a glance

  • Drugs APX 001 (Primary)
  • Indications Candidiasis
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Aug 2017 New trial record
    • 02 Aug 2017 According to an Amplyx Pharmaceuticals media release, this trial is expected to initiate later this year.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top